Smartleaf Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Smartleaf Asset Management's PFE Position: Q1 2026 in Review
Smartleaf Asset Management increased its Pfizer (PFE) stake by 17% in Q1 2026, buying an estimated $225K and bringing the position to 56,738 shares worth $1.58M. The position accounts for 0.06% of the portfolio, ranked #298.
Smartleaf Asset Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Smartleaf Asset Management held 56,738 shares of Pfizer worth $1.58M as of Q1 2026.
- Smartleaf Asset Management bought 8,445 Pfizer shares in Q1 2026, an estimated $225K.
- Pfizer made up 0.06% of Smartleaf Asset Management's portfolio in Q1 2026, its #298 holding.
- Smartleaf Asset Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.